115 related articles for article (PubMed ID: 9695962)
1. Haemopoietic transformation by the TEL/ABL oncogene.
Hannemann JR; McManus DM; Kabarowski JH; Wiedemann LM
Br J Haematol; 1998 Jul; 102(2):475-85. PubMed ID: 9695962
[TBL] [Abstract][Full Text] [Related]
2. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines.
Okuda K; Golub TR; Gilliland DG; Griffin JD
Oncogene; 1996 Sep; 13(6):1147-52. PubMed ID: 8808688
[TBL] [Abstract][Full Text] [Related]
3. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.
Lacronique V; Boureux A; Monni R; Dumon S; Mauchauffé M; Mayeux P; Gouilleux F; Berger R; Gisselbrecht S; Ghysdael J; Bernard OA
Blood; 2000 Mar; 95(6):2076-83. PubMed ID: 10706877
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells.
Spiekermann K; Pau M; Schwab R; Schmieja K; Franzrahe S; Hiddemann W
Exp Hematol; 2002 Mar; 30(3):262-71. PubMed ID: 11882364
[TBL] [Abstract][Full Text] [Related]
5. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia.
Golub TR; Goga A; Barker GF; Afar DE; McLaughlin J; Bohlander SK; Rowley JD; Witte ON; Gilliland DG
Mol Cell Biol; 1996 Aug; 16(8):4107-16. PubMed ID: 8754809
[TBL] [Abstract][Full Text] [Related]
6. The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice.
Million RP; Aster J; Gilliland DG; Van Etten RA
Blood; 2002 Jun; 99(12):4568-77. PubMed ID: 12036890
[TBL] [Abstract][Full Text] [Related]
7. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins.
Carroll M; Ohno-Jones S; Tamura S; Buchdunger E; Zimmermann J; Lydon NB; Gilliland DG; Druker BJ
Blood; 1997 Dec; 90(12):4947-52. PubMed ID: 9389713
[TBL] [Abstract][Full Text] [Related]
8. A direct binding site for Grb2 contributes to transformation and leukemogenesis by the Tel-Abl (ETV6-Abl) tyrosine kinase.
Million RP; Harakawa N; Roumiantsev S; Varticovski L; Van Etten RA
Mol Cell Biol; 2004 Jun; 24(11):4685-95. PubMed ID: 15143164
[TBL] [Abstract][Full Text] [Related]
9. The fusion of TEL and ABL in human acute lymphoblastic leukaemia is a rare event.
Janssen JW; Ridge SA; Papadopoulos P; Cotter F; Ludwig WD; Fonatsch C; Rieder H; Ostertag W; Bartram CR; Wiedemann LM
Br J Haematol; 1995 May; 90(1):222-4. PubMed ID: 7786792
[TBL] [Abstract][Full Text] [Related]
10. Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.
Adam M; Pogacic V; Bendit M; Chappuis R; Nawijn MC; Duyster J; Fox CJ; Thompson CB; Cools J; Schwaller J
Cancer Res; 2006 Apr; 66(7):3828-35. PubMed ID: 16585210
[TBL] [Abstract][Full Text] [Related]
11. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis.
Cortez D; Kadlec L; Pendergast AM
Mol Cell Biol; 1995 Oct; 15(10):5531-41. PubMed ID: 7565705
[TBL] [Abstract][Full Text] [Related]
12. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
Carlesso N; Frank DA; Griffin JD
J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
Jain SK; Langdon WY; Varticovski L
Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
[TBL] [Abstract][Full Text] [Related]
14. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways.
Carroll M; Tomasson MH; Barker GF; Golub TR; Gilliland DG
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14845-50. PubMed ID: 8962143
[TBL] [Abstract][Full Text] [Related]
15. Bcr: a negative regulator of the Bcr-Abl oncoprotein.
Wu Y; Ma G; Lu D; Lin F; Xu HJ; Liu J; Arlinghaus RB
Oncogene; 1999 Aug; 18(31):4416-24. PubMed ID: 10442632
[TBL] [Abstract][Full Text] [Related]
16. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia.
Lacronique V; Boureux A; Valle VD; Poirel H; Quang CT; Mauchauffé M; Berthou C; Lessard M; Berger R; Ghysdael J; Bernard OA
Science; 1997 Nov; 278(5341):1309-12. PubMed ID: 9360930
[TBL] [Abstract][Full Text] [Related]
17. Constitutively active ABL family kinases, TEL/ABL and TEL/ARG, harbor distinct leukemogenic activities in vivo.
Yokota A; Hirai H; Shoji T; Maekawa T; Okuda K
Leukemia; 2017 Dec; 31(12):2742-2751. PubMed ID: 28386107
[TBL] [Abstract][Full Text] [Related]
18. The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways.
Voss J; Posern G; Hannemann JR; Wiedemann LM; Turhan AG; Poirel H; Bernard OA; Adermann K; Kardinal C; Feller SM
Oncogene; 2000 Mar; 19(13):1684-90. PubMed ID: 10763825
[TBL] [Abstract][Full Text] [Related]
19. Constitutive 53BP1/γH2AX foci are increased in cells of ALL patients dependent on BCR-ABL and TEL-AML1 preleukemic gene fusions.
Somsedikova A; Markova E; Kolenova A; Puskacova J; Kubes M; Belyaev I
Neoplasma; 2014; 61(5):617-25. PubMed ID: 25244981
[TBL] [Abstract][Full Text] [Related]
20. Lack of TEL-AML1 fusion transcript resulting from a cryptic t(12;21) in adult B lineage acute lymphoblastic leukemia in Taiwan.
Shih LY; Chou TB; Liang DC; Tzeng YS; Rubnitz JE; Downing JR; Pui CH
Leukemia; 1996 Sep; 10(9):1456-8. PubMed ID: 8751462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
